Med peer benchmarking: select actual biotech/pharma peers via the med universe (drug/indication overlap where possible) and compare med-relevant metrics — pipeline depth, catalyst density, cash position, margins, valuation multiples.
Scanned 9/7/2026
Install to Claude Code
npx -y skills add agentii-ai/agentii-investment-intelligence --skill peer-bench --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Peer Bench?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/agentii-ai-peer-bench-agentii-investment-intelligenc)More formats (shields.io, HTML) on the badges page.
---
name: peer-bench
description: "Med peer benchmarking: select actual biotech/pharma peers via the med universe (drug/indication overlap where possible) and compare med-relevant metrics — pipeline depth, catalyst density, cash position, margins, valuation multiples."
multi_ticker_semantics: basket_v1_1
temporal_scope:
default_quarters: 4
max_quarters: 12
description: "Benchmark window default 4 quarters; up to 12 for multi-year pipeline comparisons."
allowed_tools:
- search_companies
- get_company_profile
- search_xbrl_facts
- get_financial_ratios
- get_peer_comparison
- get_company_drugs
- search_investment_cases
- get_investment_case
- search_investment_strategies
- get_investment_strategy
- search_by_analogue
- search_knowledge_entries
- get_knowledge_entry
retrieval_scope: structured_only
min_tool_diversity: 3
parameter_free: false
---
> Methodology inspired by publicly taught peer-comparison frameworks; all text is an original paraphrase.
## Defaults
| Parameter | Default Value | Rationale |
|-----------|---------------|-----------|
| peer_count | 4-6 | Comparable-set size standard for comps |
| peer_logic | indication/drug overlap first | Med peers are defined by science, not SIC codes |
| include_med_metrics | true | Pipeline depth, catalyst density, cash runway |
## Preflight
Run canonical pre-flight per `contracts/preflight.md`. Propagate X-Agentii-Trace per `contracts/x-agentii-trace-header.md`.
## Triggers
- "Who are the closest peers to [biotech ticker]?"
- "Benchmark [ticker] against its biotech comp set."
- "How does [ticker]'s valuation compare to peers?"
- "Which names compete with [ticker]'s pipeline?"
- "Build a peer table with pipeline depth and cash."
- "Is [ticker] expensive relative to its med peers?"
- "Compare margins across the pharma peer group."
- "What are the catalyst-dense names in this peer set?"
- "Peer analysis for [ticker] with indication overlap."
- "Which peers have the strongest balance sheets?"
## Production Grounding
- Med peers are science-defined: use `get_company_drugs` to find indication/therapy overlap before financial comparison.
- Med-relevant metrics: pipeline assets by phase, catalyst density (PDUFA/AdCom/trial readouts), cash runway (quarters), R&D productivity; generic margins only as secondary.
- Grounding frameworks: `references/knowledge-frameworks.md` (道/法 review knowledge + valuation lenses).
## Data Source Priority
1. `get_company_drugs` / `search_companies` — peer discovery by drug/indication overlap.
2. `get_financial_ratios` / `search_xbrl_facts` — financial comparison data.
3. `get_peer_comparison` — platform pre-computed peer metrics.
4. Knowledge layer: `search_investment_cases`/`search_by_analogue` for historical peer dynamics.
## Methodology
### Retrieval Scope
structured_only
### Retrieval Strategy
1. Resolve the target via `get_company_profile`; pull its drugs (`get_company_drugs`).
2. Find peers by indication/therapy overlap + med industry membership (`search_companies`).
3. Pull per-peer financials (`get_financial_ratios`) + valuation context.
4. Ground with historical cases/analogues via knowledge tools.
### Temporal Scope
See frontmatter temporal_scope block.
### Tool Allowlist
See frontmatter allowed_tools.
### Protocol
1. Target profile
2. Science-based peer selection
3. Med-metric comparison
4. Valuation & risk synthesis
## Modes
- **Science-based** (default): indication/drug-overlap peers.
- **Financial**: margin/valuation peers within the same industry.
- **Catalyst**: peers ranked by upcoming FDA events.
## Tool Fallbacks
| Failure | Fallback |
|---------|----------|
| get_company_drugs empty | Fall back to industry peers via `search_companies`; annotate |
| get_peer_comparison empty | Build comparison manually from `get_financial_ratios` |
| Knowledge tools empty | Proceed with structured data only |
## Output File
`{ticker}/{YYYY-MM-DD_HHMM}_peer-bench_{affix}.md`
## Output Structure
1. **Executive Summary** — relative standing in 2-3 sentences
2. **Peer Selection** — peers + selection logic (science overlap)
3. **Comparison Table** — med metrics + financials + valuation
4. **Historical Context** — cases/analogues with /v/ citations
5. **Risk Assessment** — concentration/catalyst risks
6. **Coverage Gaps** — missing data flags
## Error Handling
| Error | Fallback |
|-------|----------|
| No indication overlap found | Widen to same-industry peers; flag science-overlap unavailable |
| Missing financials | Mark N/A in table; do not fabricate |
## Memory Load
See `contracts/memory-load.md`.
## Snapshot
See `contracts/snapshot-synthesis.md`.
## Final Summary (TUI)
Include ### Key Citations block with 0-10 clickable /v/ URLs.
## References
- `contracts/citation-and-memory.md`
- `contracts/output-frontmatter-schema.md`
- `contracts/memory-load.md`
- `contracts/snapshot-synthesis.md`
- `contracts/preflight.md`
- `references/knowledge-frameworks.md`
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!